Santarus, Inc.

Dermata Therapeutics, Inc.

Cosmo Technologies Limited

Gerald T Proehl

Luigi Moro

Kay Olmstead

Warren Hall

Christopher Joseph Nardo

Wendell Wierenga

Michael Fangching Huang

Emerson David Ballard Ii

The present disclosure relates to the treatment of skin condition in a subject, including acne vulgaris, comprising applying to the skin of the subject a first composition comprising, and a second composition comprising one or more fluidizing agents, such as water, saline or a hydrogen peroxide solution. The disclosure also relates to a products or kits for the treatment of skin conditions in a subject, including acne vulgaris, comprising, and a second composition comprising one or more fluidizing agents, such as water, saline or a hydrogen peroxide solution, such as a 3% by weight solution of hydrogen peroxide.

Compositions and methods for the treatment of skin conditions

The present invention relates to pharmaceutical formulations comprising at least one acid-labile proton pump inhibiting agent and at least one antacid, which have improved bioavailability, chemical stability, physical stability, dissolution profiles, disintegration times, safety, as well as other improved pharmacokinetic, pharmacodynamic, chemical and/or physical properties. The present invention is directed to methods, kits, combinations, and compositions for treating, preventing or reducing the risk of developing a gastrointestinal disorder or disease, or the symptoms associated with, or related to, a gastrointestinal disorder or disease in a subject in need thereof.

Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them

Growing community of inventors

San Diego, CA, United States of America

Gerald T Proehl